In last trading session, Teladoc Health Inc (NYSE:TDOC) saw 2.89 million shares changing hands with its beta currently measuring 0.94. Company’s recent per share price level of $15.00 trading at -$0.28 or -1.83% at ring of the bell on the day assigns it a market valuation of $2.51B. That closing price of TDOC’s stock is at a discount of -102.73% from its 52-week high price of $30.41 and is indicating a premium of 4.73% from its 52-week low price of $14.29. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 3.92 million shares which gives us an average trading volume of 4.70 million if we extend that period to 3-months.
Teladoc Health Inc (NYSE:TDOC) trade information
Upright in the red during last session for losing -1.83%, in the last five days TDOC remained trading in the red while hitting it’s week-highest on Thursday, 03/21/24 when the stock touched $15.00 price level, adding 4.34% to its value on the day. Teladoc Health Inc’s shares saw a change of -30.39% in year-to-date performance and have moved -0.79% in past 5-day. Teladoc Health Inc (NYSE:TDOC) showed a performance of -1.38% in past 30-days. Number of shares sold short was 21.6 million shares which calculate 3.67 days to cover the short interests.
Teladoc Health Inc (TDOC) estimates and forecasts
Statistics highlight that Teladoc Health Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -22.32% of value to its shares in past 6 months, showing an annual growth rate of 20.15% while that of industry is 12.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024. The company is estimating its revenue growth to decrease by -9.50% in the current quarter and calculating 25.00% increase in the next quarter. This year revenue growth is estimated to rise 2.50% from the last financial year’s standing.
24 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $637.44 million for the same. And 24 analysts are in estimates of company making revenue of $663.06 million in the next quarter that will end on Jun 2024. Company posted $618.31 million and $649.19 million of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to grow by 3.10% while estimating it to be 2.10% for the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 1.91% during past 5 years.
TDOC Dividends
Teladoc Health Inc is more likely to be releasing its next quarterly report between April 24 and April 29 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Teladoc Health Inc (NYSE:TDOC)’s Major holders
Insiders are in possession of 0.79% of company’s total shares while institution are holding 75.88 percent of that, with stock having share float percentage of 76.48%. Investors also watch the number of corporate investors in a company very closely, which is 75.88% institutions for Teladoc Health Inc that are currently holding shares of the company. ARK Investment Management, LLC is the top institutional holder at TDOC for having 21.22 million shares of worth $318.37 million. And as of Dec 30, 2023, it was holding 12.71% of the company’s outstanding shares.
The second largest institutional holder is Vanguard Group Inc, which was holding about 17.52 million shares on Dec 30, 2023. The number of shares represents firm’s hold over 10.49% of outstanding shares, having a total worth of $262.73 million.
On the other hand, ARK ETF Tr-ARK Innovation ETF and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jan 30, 2024, the former fund manager was holding 11.84 million shares of worth $177.62 million or 7.09% of the total outstanding shares. The later fund manager was in possession of 5.47 million shares on Dec 30, 2023, making its stake of worth around $81.98 million in the company or a holder of 3.27% of company’s stock.
